CommentaryFull Access
Published Online:3 Nov 2020https://doi.org/10.1176/appi.ajp.2020.20020134
- Cited by
- 4 January 2024 | Discover Mental Health, Vol. 4, No. 1
- 27 June 2023 | Neuropsychopharmacology, Vol. 49, No. 1
- 17 July 2023 | Neuropsychopharmacology, Vol. 49, No. 1
- Neuropharmacology, Vol. 223
- Psihiatru.ro, Vol. 4, No. 75
- Current Neuropharmacology, Vol. 20, No. 7
- Pharmacology & Therapeutics, Vol. 234
- Pharmacology Biochemistry and Behavior, Vol. 213
- Journal of Pharmaceutical and Biomedical Analysis, Vol. 206
- David R. Rubinow,
M.D. , - Robert Lasser,
M.D., M.B.A. , - Stephen J. Kanes,
M.D., Ph.D.
22 June 2021 | American Journal of Psychiatry, Vol. 178, No. 6- David R. Rubinow,
- Robert A. Kleinman,
M.D. , - Alan F. Schatzberg,
M.D.
22 June 2021 | American Journal of Psychiatry, Vol. 178, No. 6- Robert A. Kleinman,
- 26 April 2021 | CNS Drugs, Vol. 35, No. 5
- Ned H. Kalin,
M.D.
1 March 2021 | American Journal of Psychiatry, Vol. 178, No. 3- Ned H. Kalin,